|
FIC20230014I1
(en)
|
|
Foslevodopa and foscarbidopa
|
|
DK3393510T3
(en)
|
|
ZIKAVIRUS VACCINE
|
|
DK3234133T3
(en)
|
|
CRISPR-BASED COMPOSITIONS AND METHODS OF USE
|
|
DK3145493T3
(en)
|
|
METHODS AND COMPOSITIONS RELATING TO EXOSOMES
|
|
BR112016016289A2
(en)
|
|
heteroari and uses thereof
|
|
DK3152607T3
(en)
|
|
AND ANTIRESONANT HELPFIBER
|
|
DK3018183T3
(en)
|
|
HALOGENOLEFIN BASED COMPOSITION AND USE THEREOF
|
|
MA40933A
(en)
|
|
DIFLUOROMETHYL-AMINOPYRIDINES AND DIFLUOROMETHYL-AMINOPYRIMIDINES
|
|
KR20180084891A
(en)
|
|
Structural compositions and methods
|
|
HK1225645A1
(en)
|
|
Pcv2b divergent vaccine composition and methods of use
|
|
BR112016020889A2
(en)
|
|
hppd variants and methods of use
|
|
DK3129007T3
(en)
|
|
Vaccine compositions
|
|
FI20146023A
(en)
|
|
Dental and tongue support
|
|
DK3137873T3
(en)
|
|
VISCOMETER AND METHODS OF USE THEREOF
|
|
DK3205661T3
(en)
|
|
HSP70-DERIVED IMMUNITY-INDUCING PEPTIME
|
|
BR112017018932A2
(en)
|
|
etv2 and uses thereof
|
|
SG11201704942QA
(en)
|
|
Dengue virus vaccine compositions and methods of use thereof
|
|
FI20145808A
(en)
|
|
Mixing device and its use
|
|
DK3233104T3
(en)
|
|
IMMUNTERY TREATMENTS AND COMPOSITIONS
|
|
DK3185813T3
(en)
|
|
Approach to dental virtual model basis
|
|
DK3148513T3
(en)
|
|
Ceritinib formulation
|
|
FR3021528B1
(en)
|
|
COSMETIC FORMULATION
|
|
DK3099314T3
(en)
|
|
Tolerogenic compositions and uses thereof
|
|
DK3193856T3
(en)
|
|
Formulation
|
|
FR3026639B1
(en)
|
|
COSMETIC COMPOSITION
|